13 February 2026

Pharma in Healthcare

J&J reveals plan to build two US manufacturing sites

Johnson & Johnson has shaken-hands on a most-favoured-nation (MFN) drug pricing deal with the Trump administration. With the agreement—which frees J&J up from tariffs on...

ExpreS2ion selects Northway Biotech as manufacturing partner for Nipah virus vaccine programme

ExpreS2ion Biotechnologies has selected Northway Biotech as its cGMP contract development and manufacturing organisation (CDMO) for its Nipah virus vaccine candidate. The programme is being...

Alexion, Astrazeneca and Wolves Foundation unite to raise awareness of rare disease

Alexion, AstraZeneca Rare Disease, and Wolves Foundation have announced a new partnership to raise awareness of rare diseases and support the Foundation’s disability football...

Enzymatica becomes official supplier of the Swedish Biathlon Federation

Enzymatica is proud to announce a partnership with the Swedish Biathlon Federation, under which Enzymatica becomes an official supplier to the national federation. The collaboration focuses on initiatives...

Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US

Sanofi US announces a broad expansion of its Insulins Valyou Savings Program by offering a 30-day supply of any Sanofi insulin for $35 to all patients in...

Astoriom appoints new Chief Executive Officer to support global scale-up of sample management operations

Astoriom has announced the appointment of Will Edwards as Chief Executive Officer. He will continue to build on Astoriom’s strong foundations to support the next...

Regulatory update on use of AMT-130 for Huntington’s Disease

UniQure, a leading gene therapy company advancing transformative therapies for patients with severe medical needs, has announced that the company received final meeting minutes...

Health and life sciences in 2026: data earns its doctorate and AI prescribes the future of care

As we step into 2026, the AI and analytics story for health care and life sciences isn’t about sudden disruption – it’s about a...
- Advertisement -spot_img
- Advertisement -
- Advertisement -

Latest stories